Salmeterol, inhaled corticosteroids, and tolerance to allergen bronchoprotection.
Cockcroft
D W
DW
Davis
B E
BE
Swystun
V A
VA
D000280:Administration, Inhalation; D000318:Adrenergic beta-Agonists / Q000627:therapeutic use*; D000420:Albuterol / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000485:Allergens / Q000009:adverse effects*; D001249:Asthma / Q000188:drug therapy* / Q000209:etiology; D001507:Beclomethasone / Q000627:therapeutic use*; D004342:Drug Hypersensitivity / Q000209:etiology / Q000517:prevention & control*; D005938:Glucocorticoids / Q000008:administration & dosage*; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D012107:Research Design; D000068299:Salmeterol Xinafoate
D000318:Adrenergic beta-Agonists; D000485:Allergens; D005938:Glucocorticoids; D000068299:Salmeterol Xinafoate; D001507:Beclomethasone; D000420:Albuterol